Search company, investor...

Oxford Cancer Biomarkers

oxfordbio.com

Founded Year

2011

Stage

Spinoff / Spinout | Alive

About Oxford Cancer Biomarkers

Oxford Cancer Biomarkers develops biomarker technology products.

Headquarters Location

Magdalen Centre Oxford Science Park Robert Robertson Avenue

Oxford, England, OX4 4GA,

United Kingdom

+44 01865784743

Missing: Oxford Cancer Biomarkers's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Oxford Cancer Biomarkers's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Oxford Cancer Biomarkers

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Oxford Cancer Biomarkers is included in 1 Expert Collection, including Cancer.

C

Cancer

3,605 items

Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.

Oxford Cancer Biomarkers Patents

Oxford Cancer Biomarkers has filed 1 patent.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

3/10/2016

11/5/2019

Oncology, Pathology, Rare cancers, Cancer, Anatomical pathology

Grant

Application Date

3/10/2016

Grant Date

11/5/2019

Title

Related Topics

Oncology, Pathology, Rare cancers, Cancer, Anatomical pathology

Status

Grant

Oxford Cancer Biomarkers Frequently Asked Questions (FAQ)

  • When was Oxford Cancer Biomarkers founded?

    Oxford Cancer Biomarkers was founded in 2011.

  • Where is Oxford Cancer Biomarkers's headquarters?

    Oxford Cancer Biomarkers's headquarters is located at Magdalen Centre, Oxford.

  • What is Oxford Cancer Biomarkers's latest funding round?

    Oxford Cancer Biomarkers's latest funding round is Spinoff / Spinout.

  • Who are the investors of Oxford Cancer Biomarkers?

    Investors of Oxford Cancer Biomarkers include University of Oxford.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.